Trial
NCT00498056
Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Centers for Disease Control and Prevention; HIV Vaccine Trials Network; International AIDS Vaccine Initiative; US Military HIV Research Program; Vaccine Research Center
Condition
HIV Infections
Intervention
VRC-HIVDNA016-00-VP
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-01